Literature DB >> 21282741

Increased in vivo efficacy of lenalidomide by addition of piroctone olamine.

Young Kim1, Petra Alpmann, Sabine Blaum-Feder, Simon Krämer, Tomoyuki Endo, Desheng Lu, Dennis Carson, Ingo G H Schmidt-Wolf.   

Abstract

BACKGROUND: It was recently confirmed that the antifungal agent ciclopirox olamine inhibits Wnt/beta catenin signaling in myeloma. Piroctone olamine (PO) has very similar chemical features to ciclopirox olamine.
MATERIALS AND METHODS: This study investigated the antitumor effect of PO in vitro and in vivo in a murine myeloma model.
RESULTS: PO demonstrated a major apoptotic activity in various human and murine myeloma and lymphoma cell lines, as well as in human primary cells. In vivo, tumor growth, as well as overall survival, was significantly reduced in mice treated with PO as compared to untreated mice. Interestingly, concerning tumor growth and survival of the animals, a significant additive effect was seen by the combination of lenalidomide plus PO as compared to single application.
CONCLUSION: These results reveal a significant selective induction of apoptosis by PO and suggest a significant in vivo effect against myeloma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282741

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  5 in total

1.  Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.

Authors:  Ahmad M Al-Dali; Hans Weiher; Ingo G H Schmidt-Wolf
Journal:  Oncol Lett       Date:  2018-09-20       Impact factor: 2.967

2.  Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study.

Authors:  Hae Jeong Youn; Soo Young Kim; Minji Park; Won Hee Jung; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

Review 3.  Cosmetics Preservation: A Review on Present Strategies.

Authors:  Noureddine Halla; Isabel P Fernandes; Sandrina A Heleno; Patrícia Costa; Zahia Boucherit-Otmani; Kebir Boucherit; Alírio E Rodrigues; Isabel C F R Ferreira; Maria Filomena Barreiro
Journal:  Molecules       Date:  2018-06-28       Impact factor: 4.411

4.  Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.

Authors:  Y Kim; S Thanendrarajan; I G H Schmidt-Wolf
Journal:  Leuk Res Treatment       Date:  2011-12-01

5.  Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis.

Authors:  Fabíola Maria Marques do Couto; Silene Carneiro do Nascimento; Silvio Francisco Pereira Júnior; Vanessa Karina Alves da Silva; André Ferraz Goiana Leal; Rejane Pereira Neves
Journal:  Springerplus       Date:  2016-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.